155 related articles for article (PubMed ID: 32806777)
1. MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer.
Cataldo A; Romero-Cordoba S; Plantamura I; Cosentino G; Hidalgo-Miranda A; Tagliabue E; Iorio MV
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32806777
[No Abstract] [Full Text] [Related]
2. miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response.
Cataldo A; Cheung DG; Balsari A; Tagliabue E; Coppola V; Iorio MV; Palmieri D; Croce CM
Oncotarget; 2016 Jan; 7(1):786-97. PubMed ID: 26623722
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG10 suppresses the development of doxorubicin resistance by downregulating miR-302b in triple-negative breast cancer.
Aini S; Bolati S; Ding W; Liu S; Su P; Aili S; Naman Y; Xuekelaiti K
Bioengineered; 2022 May; 13(5):11430-11439. PubMed ID: 35506202
[TBL] [Abstract][Full Text] [Related]
4. Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulation.
De Cecco L; Berardi M; Sommariva M; Cataldo A; Canevari S; Mezzanzanica D; Iorio MV; Tagliabue E; Balsari A
PLoS One; 2013; 8(3):e58849. PubMed ID: 23484053
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer.
Tang T; Cheng Y; She Q; Jiang Y; Chen Y; Yang W; Li Y
Biomed Pharmacother; 2018 Nov; 107():338-346. PubMed ID: 30098551
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: Findings based on RT-qPCR and in silico analysis.
Wu HY; Cai KT; Ma J; Chen G; Dang YW; Lu HP; Pan SL
Pathol Res Pract; 2019 Jul; 215(7):152424. PubMed ID: 31103408
[TBL] [Abstract][Full Text] [Related]
7. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-302b suppresses human epithelial ovarian cancer cell growth by targeting RUNX1.
Ge T; Yin M; Yang M; Liu T; Lou G
Cell Physiol Biochem; 2014; 34(6):2209-20. PubMed ID: 25562167
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
11. miR-5590-3p-YY1 feedback loop promotes the proliferation and migration of triple-negative breast cancer cells.
Liang F; Fu X; Wang L
J Cell Biochem; 2019 Oct; 120(10):18415-18424. PubMed ID: 31190375
[TBL] [Abstract][Full Text] [Related]
12. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
Guo GC; Wang JX; Han ML; Zhang LP; Li L
Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
[TBL] [Abstract][Full Text] [Related]
13. miRNA-302b suppresses human hepatocellular carcinoma by targeting AKT2.
Wang L; Yao J; Zhang X; Guo B; Le X; Cubberly M; Li Z; Nan K; Song T; Huang C
Mol Cancer Res; 2014 Feb; 12(2):190-202. PubMed ID: 24337067
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer.
Wang S; Oh DY; Leventaki V; Drakos E; Zhang R; Sahin AA; Resetkova E; Edgerton ME; Wu W; Claret FX
Cancer Lett; 2019 Nov; 465():12-23. PubMed ID: 31473252
[TBL] [Abstract][Full Text] [Related]
15. [Effect of miR-342-3p on chemotherapy sensitivity in triple-negative breast cancer].
Ma T; Zhang J; Wu J; Tang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 May; 39(5):488-95. PubMed ID: 24921394
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-302b negatively regulates IL-1β production in response to MSU crystals by targeting IRAK4 and EphA2.
Ma T; Liu X; Cen Z; Xin C; Guo M; Zou C; Song W; Xie R; Wang K; Zhou H; Zhang J; Wang Z; Bian C; Cui K; Li J; Wei YQ; Li J; Zhou X
Arthritis Res Ther; 2018 Feb; 20(1):34. PubMed ID: 29482609
[TBL] [Abstract][Full Text] [Related]
17. MiR-302b Suppresses Osteosarcoma Cell Migration and Invasion by Targeting Runx2.
Xie Y; Sun W; Deng Z; Zhu X; Hu C; Cai L
Sci Rep; 2017 Oct; 7(1):13388. PubMed ID: 29042587
[TBL] [Abstract][Full Text] [Related]
18. miR-302b inhibits cancer-related inflammation by targeting ERBB4, IRF2 and CXCR4 in esophageal cancer.
Zhang M; Zhang L; Cui M; Ye W; Zhang P; Zhou S; Wang J
Oncotarget; 2017 Jul; 8(30):49053-49063. PubMed ID: 28467773
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of microRNA-302b-3p relieves oxygen-glucose deprivation/re-oxygenation induced injury in murine hippocampal neurons through up-regulating Nrf2 signaling by targeting fibroblast growth factor 15/19.
Zhang Z; Wang N; Zhang Y; Zhao J; Lv J
Chem Biol Interact; 2019 Aug; 309():108705. PubMed ID: 31199929
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of miR-302b, an ESC-specific microRNA, in Gastric Adenocarcinoma.
Khalili M; Sadeghizadeh M; Ghorbanian K; Malekzadeh R; Vasei M; Mowla SJ
Cell J; 2012; 13(4):251-8. PubMed ID: 23508453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
